Global Microarray research
Global Microarray research

Microarray Comprehensive Study by Type (DNA Microarray, Oligonucleotide Microarray, Protein Microarray, Tissue Microarray), Application (Gene expression, Disease diagnosis and development), End Use (Life Science Research, Medical, Others) Players and Region - Global Market Outlook to 2024

Microarray Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024 | CAGR: 8.3%  

Jun 2019 Edition 236 Pages 165 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Market Snapshot:
A microarray is refer as a tiny, bio-compatible silicon chip which is capable of rapid identification and also precise multiplexed analysis of nucleic acids (DNA/RNA). In developed countries, presently DNA Microarray industry is generally at a more advanced level. A microarray is a known as a laboratory tool which is been used to detect the thousands of expression of genes at the same time. Microarray provides accuracy and precision in disease diagnosis and drug discovery which is driving the market, while some of the factors like high cost associated with array instrument and lack of expertise to operate microarray technology is threatening the market.

Market Drivers
  • Provides Accuracy and Precision in Disease Diagnosis and Drug Discovery

Market Trend
  • Emphasizing on Customize Treatments for Certain Deadly Diseases such as Cancer

Restraints
  • High Cost Associated With Array Instrument
  • Lack of Expertise to Operate Microarray Technology


The key Players profiled in the report are Thermo Fischer Scientific (United States), Agilent Technologies (United States), Merck (United States), Illumina Inc. (United States), Phalanx Biotech (Taiwan), Biometrix Technology (Korea), Perkin Elmer (United States), Applied Microarrays (United States), Array It Corporation (United States) and TAKARA BIO INC. (Japan). Additionally, other players that are part of this comprehensive study are BioGenex (United States), LC Sciences (United States), US Biomax (United States), AXO Science (France) and Qiagen (Germany).

Report Objectives / Segmentation Covered
By Type
  • DNA Microarray
  • Oligonucleotide Microarray
  • Protein Microarray
  • Tissue Microarray
By Application
  • Gene expression
  • Disease diagnosis and development
By End Use
  • Life Science Research
  • Medical
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Provides Accuracy and Precision in Disease Diagnosis and Drug Discovery
    • 3.3. Market Challenges
      • 3.3.1. Making Cost Effective Tissue Microarrays
    • 3.4. Market Trends
      • 3.4.1. Emphasizing on Customize Treatments for Certain Deadly Diseases such as Cancer
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Microarray, by Type, Application, End Use and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Microarray (Value)
      • 5.2.1. Global Microarray by: Type (Value)
        • 5.2.1.1. DNA Microarray
        • 5.2.1.2. Oligonucleotide Microarray
        • 5.2.1.3. Protein Microarray
        • 5.2.1.4. Tissue Microarray
      • 5.2.2. Global Microarray by: Application (Value)
        • 5.2.2.1. Gene expression
        • 5.2.2.2. Disease diagnosis and development
      • 5.2.3. Global Microarray by: End Use (Value)
        • 5.2.3.1. Life Science Research
        • 5.2.3.2. Medical
        • 5.2.3.3. Others
      • 5.2.4. Global Microarray Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Microarray (Volume)
      • 5.3.1. Global Microarray by: Type (Volume)
        • 5.3.1.1. DNA Microarray
        • 5.3.1.2. Oligonucleotide Microarray
        • 5.3.1.3. Protein Microarray
        • 5.3.1.4. Tissue Microarray
      • 5.3.2. Global Microarray by: Application (Volume)
        • 5.3.2.1. Gene expression
        • 5.3.2.2. Disease diagnosis and development
      • 5.3.3. Global Microarray by: End Use (Volume)
        • 5.3.3.1. Life Science Research
        • 5.3.3.2. Medical
        • 5.3.3.3. Others
      • 5.3.4. Global Microarray Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Microarray (Price)
      • 5.4.1. Global Microarray by: Type (Price)
  • 6. Microarray: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fischer Scientific (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Agilent Technologies (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Illumina Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Phalanx Biotech (Taiwan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Biometrix Technology (Korea)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Perkin Elmer (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Applied Microarrays (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Array It Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. TAKARA BIO INC. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Microarray Sale, by Type, Application, End Use and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Microarray (Value)
      • 7.2.1. Global Microarray by: Type (Value)
        • 7.2.1.1. DNA Microarray
        • 7.2.1.2. Oligonucleotide Microarray
        • 7.2.1.3. Protein Microarray
        • 7.2.1.4. Tissue Microarray
      • 7.2.2. Global Microarray by: Application (Value)
        • 7.2.2.1. Gene expression
        • 7.2.2.2. Disease diagnosis and development
      • 7.2.3. Global Microarray by: End Use (Value)
        • 7.2.3.1. Life Science Research
        • 7.2.3.2. Medical
        • 7.2.3.3. Others
      • 7.2.4. Global Microarray Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Microarray (Volume)
      • 7.3.1. Global Microarray by: Type (Volume)
        • 7.3.1.1. DNA Microarray
        • 7.3.1.2. Oligonucleotide Microarray
        • 7.3.1.3. Protein Microarray
        • 7.3.1.4. Tissue Microarray
      • 7.3.2. Global Microarray by: Application (Volume)
        • 7.3.2.1. Gene expression
        • 7.3.2.2. Disease diagnosis and development
      • 7.3.3. Global Microarray by: End Use (Volume)
        • 7.3.3.1. Life Science Research
        • 7.3.3.2. Medical
        • 7.3.3.3. Others
      • 7.3.4. Global Microarray Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Microarray (Price)
      • 7.4.1. Global Microarray by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Microarray: by Type(USD Million)
  • Table 2. Microarray DNA Microarray , by Region USD Million (2013-2018)
  • Table 3. Microarray Oligonucleotide Microarray , by Region USD Million (2013-2018)
  • Table 4. Microarray Protein Microarray , by Region USD Million (2013-2018)
  • Table 5. Microarray Tissue Microarray , by Region USD Million (2013-2018)
  • Table 6. Microarray: by Application(USD Million)
  • Table 7. Microarray Gene expression , by Region USD Million (2013-2018)
  • Table 8. Microarray Disease diagnosis and development , by Region USD Million (2013-2018)
  • Table 9. Microarray: by End Use(USD Million)
  • Table 10. Microarray Life Science Research , by Region USD Million (2013-2018)
  • Table 11. Microarray Medical , by Region USD Million (2013-2018)
  • Table 12. Microarray Others , by Region USD Million (2013-2018)
  • Table 13. South America Microarray, by Country USD Million (2013-2018)
  • Table 14. South America Microarray, by Type USD Million (2013-2018)
  • Table 15. South America Microarray, by Application USD Million (2013-2018)
  • Table 16. South America Microarray, by End Use USD Million (2013-2018)
  • Table 17. Brazil Microarray, by Type USD Million (2013-2018)
  • Table 18. Brazil Microarray, by Application USD Million (2013-2018)
  • Table 19. Brazil Microarray, by End Use USD Million (2013-2018)
  • Table 20. Argentina Microarray, by Type USD Million (2013-2018)
  • Table 21. Argentina Microarray, by Application USD Million (2013-2018)
  • Table 22. Argentina Microarray, by End Use USD Million (2013-2018)
  • Table 23. Rest of South America Microarray, by Type USD Million (2013-2018)
  • Table 24. Rest of South America Microarray, by Application USD Million (2013-2018)
  • Table 25. Rest of South America Microarray, by End Use USD Million (2013-2018)
  • Table 26. Asia Pacific Microarray, by Country USD Million (2013-2018)
  • Table 27. Asia Pacific Microarray, by Type USD Million (2013-2018)
  • Table 28. Asia Pacific Microarray, by Application USD Million (2013-2018)
  • Table 29. Asia Pacific Microarray, by End Use USD Million (2013-2018)
  • Table 30. China Microarray, by Type USD Million (2013-2018)
  • Table 31. China Microarray, by Application USD Million (2013-2018)
  • Table 32. China Microarray, by End Use USD Million (2013-2018)
  • Table 33. Japan Microarray, by Type USD Million (2013-2018)
  • Table 34. Japan Microarray, by Application USD Million (2013-2018)
  • Table 35. Japan Microarray, by End Use USD Million (2013-2018)
  • Table 36. India Microarray, by Type USD Million (2013-2018)
  • Table 37. India Microarray, by Application USD Million (2013-2018)
  • Table 38. India Microarray, by End Use USD Million (2013-2018)
  • Table 39. South Korea Microarray, by Type USD Million (2013-2018)
  • Table 40. South Korea Microarray, by Application USD Million (2013-2018)
  • Table 41. South Korea Microarray, by End Use USD Million (2013-2018)
  • Table 42. Taiwan Microarray, by Type USD Million (2013-2018)
  • Table 43. Taiwan Microarray, by Application USD Million (2013-2018)
  • Table 44. Taiwan Microarray, by End Use USD Million (2013-2018)
  • Table 45. Australia Microarray, by Type USD Million (2013-2018)
  • Table 46. Australia Microarray, by Application USD Million (2013-2018)
  • Table 47. Australia Microarray, by End Use USD Million (2013-2018)
  • Table 48. Rest of Asia-Pacific Microarray, by Type USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Microarray, by Application USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Microarray, by End Use USD Million (2013-2018)
  • Table 51. Europe Microarray, by Country USD Million (2013-2018)
  • Table 52. Europe Microarray, by Type USD Million (2013-2018)
  • Table 53. Europe Microarray, by Application USD Million (2013-2018)
  • Table 54. Europe Microarray, by End Use USD Million (2013-2018)
  • Table 55. Germany Microarray, by Type USD Million (2013-2018)
  • Table 56. Germany Microarray, by Application USD Million (2013-2018)
  • Table 57. Germany Microarray, by End Use USD Million (2013-2018)
  • Table 58. France Microarray, by Type USD Million (2013-2018)
  • Table 59. France Microarray, by Application USD Million (2013-2018)
  • Table 60. France Microarray, by End Use USD Million (2013-2018)
  • Table 61. Italy Microarray, by Type USD Million (2013-2018)
  • Table 62. Italy Microarray, by Application USD Million (2013-2018)
  • Table 63. Italy Microarray, by End Use USD Million (2013-2018)
  • Table 64. United Kingdom Microarray, by Type USD Million (2013-2018)
  • Table 65. United Kingdom Microarray, by Application USD Million (2013-2018)
  • Table 66. United Kingdom Microarray, by End Use USD Million (2013-2018)
  • Table 67. Netherlands Microarray, by Type USD Million (2013-2018)
  • Table 68. Netherlands Microarray, by Application USD Million (2013-2018)
  • Table 69. Netherlands Microarray, by End Use USD Million (2013-2018)
  • Table 70. Rest of Europe Microarray, by Type USD Million (2013-2018)
  • Table 71. Rest of Europe Microarray, by Application USD Million (2013-2018)
  • Table 72. Rest of Europe Microarray, by End Use USD Million (2013-2018)
  • Table 73. MEA Microarray, by Country USD Million (2013-2018)
  • Table 74. MEA Microarray, by Type USD Million (2013-2018)
  • Table 75. MEA Microarray, by Application USD Million (2013-2018)
  • Table 76. MEA Microarray, by End Use USD Million (2013-2018)
  • Table 77. Middle East Microarray, by Type USD Million (2013-2018)
  • Table 78. Middle East Microarray, by Application USD Million (2013-2018)
  • Table 79. Middle East Microarray, by End Use USD Million (2013-2018)
  • Table 80. Africa Microarray, by Type USD Million (2013-2018)
  • Table 81. Africa Microarray, by Application USD Million (2013-2018)
  • Table 82. Africa Microarray, by End Use USD Million (2013-2018)
  • Table 83. North America Microarray, by Country USD Million (2013-2018)
  • Table 84. North America Microarray, by Type USD Million (2013-2018)
  • Table 85. North America Microarray, by Application USD Million (2013-2018)
  • Table 86. North America Microarray, by End Use USD Million (2013-2018)
  • Table 87. United States Microarray, by Type USD Million (2013-2018)
  • Table 88. United States Microarray, by Application USD Million (2013-2018)
  • Table 89. United States Microarray, by End Use USD Million (2013-2018)
  • Table 90. Canada Microarray, by Type USD Million (2013-2018)
  • Table 91. Canada Microarray, by Application USD Million (2013-2018)
  • Table 92. Canada Microarray, by End Use USD Million (2013-2018)
  • Table 93. Mexico Microarray, by Type USD Million (2013-2018)
  • Table 94. Mexico Microarray, by Application USD Million (2013-2018)
  • Table 95. Mexico Microarray, by End Use USD Million (2013-2018)
  • Table 96. Microarray Sales: by Type(Y)
  • Table 97. Microarray Sales DNA Microarray , by Region Y (2013-2018)
  • Table 98. Microarray Sales Oligonucleotide Microarray , by Region Y (2013-2018)
  • Table 99. Microarray Sales Protein Microarray , by Region Y (2013-2018)
  • Table 100. Microarray Sales Tissue Microarray , by Region Y (2013-2018)
  • Table 101. Microarray Sales: by Application(Y)
  • Table 102. Microarray Sales Gene expression , by Region Y (2013-2018)
  • Table 103. Microarray Sales Disease diagnosis and development , by Region Y (2013-2018)
  • Table 104. Microarray Sales: by End Use(Y)
  • Table 105. Microarray Sales Life Science Research , by Region Y (2013-2018)
  • Table 106. Microarray Sales Medical , by Region Y (2013-2018)
  • Table 107. Microarray Sales Others , by Region Y (2013-2018)
  • Table 108. South America Microarray Sales, by Country Y (2013-2018)
  • Table 109. South America Microarray Sales, by Type Y (2013-2018)
  • Table 110. South America Microarray Sales, by Application Y (2013-2018)
  • Table 111. South America Microarray Sales, by End Use Y (2013-2018)
  • Table 112. Brazil Microarray Sales, by Type Y (2013-2018)
  • Table 113. Brazil Microarray Sales, by Application Y (2013-2018)
  • Table 114. Brazil Microarray Sales, by End Use Y (2013-2018)
  • Table 115. Argentina Microarray Sales, by Type Y (2013-2018)
  • Table 116. Argentina Microarray Sales, by Application Y (2013-2018)
  • Table 117. Argentina Microarray Sales, by End Use Y (2013-2018)
  • Table 118. Rest of South America Microarray Sales, by Type Y (2013-2018)
  • Table 119. Rest of South America Microarray Sales, by Application Y (2013-2018)
  • Table 120. Rest of South America Microarray Sales, by End Use Y (2013-2018)
  • Table 121. Asia Pacific Microarray Sales, by Country Y (2013-2018)
  • Table 122. Asia Pacific Microarray Sales, by Type Y (2013-2018)
  • Table 123. Asia Pacific Microarray Sales, by Application Y (2013-2018)
  • Table 124. Asia Pacific Microarray Sales, by End Use Y (2013-2018)
  • Table 125. China Microarray Sales, by Type Y (2013-2018)
  • Table 126. China Microarray Sales, by Application Y (2013-2018)
  • Table 127. China Microarray Sales, by End Use Y (2013-2018)
  • Table 128. Japan Microarray Sales, by Type Y (2013-2018)
  • Table 129. Japan Microarray Sales, by Application Y (2013-2018)
  • Table 130. Japan Microarray Sales, by End Use Y (2013-2018)
  • Table 131. India Microarray Sales, by Type Y (2013-2018)
  • Table 132. India Microarray Sales, by Application Y (2013-2018)
  • Table 133. India Microarray Sales, by End Use Y (2013-2018)
  • Table 134. South Korea Microarray Sales, by Type Y (2013-2018)
  • Table 135. South Korea Microarray Sales, by Application Y (2013-2018)
  • Table 136. South Korea Microarray Sales, by End Use Y (2013-2018)
  • Table 137. Taiwan Microarray Sales, by Type Y (2013-2018)
  • Table 138. Taiwan Microarray Sales, by Application Y (2013-2018)
  • Table 139. Taiwan Microarray Sales, by End Use Y (2013-2018)
  • Table 140. Australia Microarray Sales, by Type Y (2013-2018)
  • Table 141. Australia Microarray Sales, by Application Y (2013-2018)
  • Table 142. Australia Microarray Sales, by End Use Y (2013-2018)
  • Table 143. Rest of Asia-Pacific Microarray Sales, by Type Y (2013-2018)
  • Table 144. Rest of Asia-Pacific Microarray Sales, by Application Y (2013-2018)
  • Table 145. Rest of Asia-Pacific Microarray Sales, by End Use Y (2013-2018)
  • Table 146. Europe Microarray Sales, by Country Y (2013-2018)
  • Table 147. Europe Microarray Sales, by Type Y (2013-2018)
  • Table 148. Europe Microarray Sales, by Application Y (2013-2018)
  • Table 149. Europe Microarray Sales, by End Use Y (2013-2018)
  • Table 150. Germany Microarray Sales, by Type Y (2013-2018)
  • Table 151. Germany Microarray Sales, by Application Y (2013-2018)
  • Table 152. Germany Microarray Sales, by End Use Y (2013-2018)
  • Table 153. France Microarray Sales, by Type Y (2013-2018)
  • Table 154. France Microarray Sales, by Application Y (2013-2018)
  • Table 155. France Microarray Sales, by End Use Y (2013-2018)
  • Table 156. Italy Microarray Sales, by Type Y (2013-2018)
  • Table 157. Italy Microarray Sales, by Application Y (2013-2018)
  • Table 158. Italy Microarray Sales, by End Use Y (2013-2018)
  • Table 159. United Kingdom Microarray Sales, by Type Y (2013-2018)
  • Table 160. United Kingdom Microarray Sales, by Application Y (2013-2018)
  • Table 161. United Kingdom Microarray Sales, by End Use Y (2013-2018)
  • Table 162. Netherlands Microarray Sales, by Type Y (2013-2018)
  • Table 163. Netherlands Microarray Sales, by Application Y (2013-2018)
  • Table 164. Netherlands Microarray Sales, by End Use Y (2013-2018)
  • Table 165. Rest of Europe Microarray Sales, by Type Y (2013-2018)
  • Table 166. Rest of Europe Microarray Sales, by Application Y (2013-2018)
  • Table 167. Rest of Europe Microarray Sales, by End Use Y (2013-2018)
  • Table 168. MEA Microarray Sales, by Country Y (2013-2018)
  • Table 169. MEA Microarray Sales, by Type Y (2013-2018)
  • Table 170. MEA Microarray Sales, by Application Y (2013-2018)
  • Table 171. MEA Microarray Sales, by End Use Y (2013-2018)
  • Table 172. Middle East Microarray Sales, by Type Y (2013-2018)
  • Table 173. Middle East Microarray Sales, by Application Y (2013-2018)
  • Table 174. Middle East Microarray Sales, by End Use Y (2013-2018)
  • Table 175. Africa Microarray Sales, by Type Y (2013-2018)
  • Table 176. Africa Microarray Sales, by Application Y (2013-2018)
  • Table 177. Africa Microarray Sales, by End Use Y (2013-2018)
  • Table 178. North America Microarray Sales, by Country Y (2013-2018)
  • Table 179. North America Microarray Sales, by Type Y (2013-2018)
  • Table 180. North America Microarray Sales, by Application Y (2013-2018)
  • Table 181. North America Microarray Sales, by End Use Y (2013-2018)
  • Table 182. United States Microarray Sales, by Type Y (2013-2018)
  • Table 183. United States Microarray Sales, by Application Y (2013-2018)
  • Table 184. United States Microarray Sales, by End Use Y (2013-2018)
  • Table 185. Canada Microarray Sales, by Type Y (2013-2018)
  • Table 186. Canada Microarray Sales, by Application Y (2013-2018)
  • Table 187. Canada Microarray Sales, by End Use Y (2013-2018)
  • Table 188. Mexico Microarray Sales, by Type Y (2013-2018)
  • Table 189. Mexico Microarray Sales, by Application Y (2013-2018)
  • Table 190. Mexico Microarray Sales, by End Use Y (2013-2018)
  • Table 191. Microarray: by Type(USD/Units)
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Microarray: by Type(USD Million)
  • Table 203. Microarray DNA Microarray , by Region USD Million (2019-2024)
  • Table 204. Microarray Oligonucleotide Microarray , by Region USD Million (2019-2024)
  • Table 205. Microarray Protein Microarray , by Region USD Million (2019-2024)
  • Table 206. Microarray Tissue Microarray , by Region USD Million (2019-2024)
  • Table 207. Microarray: by Application(USD Million)
  • Table 208. Microarray Gene expression , by Region USD Million (2019-2024)
  • Table 209. Microarray Disease diagnosis and development , by Region USD Million (2019-2024)
  • Table 210. Microarray: by End Use(USD Million)
  • Table 211. Microarray Life Science Research , by Region USD Million (2019-2024)
  • Table 212. Microarray Medical , by Region USD Million (2019-2024)
  • Table 213. Microarray Others , by Region USD Million (2019-2024)
  • Table 214. South America Microarray, by Country USD Million (2019-2024)
  • Table 215. South America Microarray, by Type USD Million (2019-2024)
  • Table 216. South America Microarray, by Application USD Million (2019-2024)
  • Table 217. South America Microarray, by End Use USD Million (2019-2024)
  • Table 218. Brazil Microarray, by Type USD Million (2019-2024)
  • Table 219. Brazil Microarray, by Application USD Million (2019-2024)
  • Table 220. Brazil Microarray, by End Use USD Million (2019-2024)
  • Table 221. Argentina Microarray, by Type USD Million (2019-2024)
  • Table 222. Argentina Microarray, by Application USD Million (2019-2024)
  • Table 223. Argentina Microarray, by End Use USD Million (2019-2024)
  • Table 224. Rest of South America Microarray, by Type USD Million (2019-2024)
  • Table 225. Rest of South America Microarray, by Application USD Million (2019-2024)
  • Table 226. Rest of South America Microarray, by End Use USD Million (2019-2024)
  • Table 227. Asia Pacific Microarray, by Country USD Million (2019-2024)
  • Table 228. Asia Pacific Microarray, by Type USD Million (2019-2024)
  • Table 229. Asia Pacific Microarray, by Application USD Million (2019-2024)
  • Table 230. Asia Pacific Microarray, by End Use USD Million (2019-2024)
  • Table 231. China Microarray, by Type USD Million (2019-2024)
  • Table 232. China Microarray, by Application USD Million (2019-2024)
  • Table 233. China Microarray, by End Use USD Million (2019-2024)
  • Table 234. Japan Microarray, by Type USD Million (2019-2024)
  • Table 235. Japan Microarray, by Application USD Million (2019-2024)
  • Table 236. Japan Microarray, by End Use USD Million (2019-2024)
  • Table 237. India Microarray, by Type USD Million (2019-2024)
  • Table 238. India Microarray, by Application USD Million (2019-2024)
  • Table 239. India Microarray, by End Use USD Million (2019-2024)
  • Table 240. South Korea Microarray, by Type USD Million (2019-2024)
  • Table 241. South Korea Microarray, by Application USD Million (2019-2024)
  • Table 242. South Korea Microarray, by End Use USD Million (2019-2024)
  • Table 243. Taiwan Microarray, by Type USD Million (2019-2024)
  • Table 244. Taiwan Microarray, by Application USD Million (2019-2024)
  • Table 245. Taiwan Microarray, by End Use USD Million (2019-2024)
  • Table 246. Australia Microarray, by Type USD Million (2019-2024)
  • Table 247. Australia Microarray, by Application USD Million (2019-2024)
  • Table 248. Australia Microarray, by End Use USD Million (2019-2024)
  • Table 249. Rest of Asia-Pacific Microarray, by Type USD Million (2019-2024)
  • Table 250. Rest of Asia-Pacific Microarray, by Application USD Million (2019-2024)
  • Table 251. Rest of Asia-Pacific Microarray, by End Use USD Million (2019-2024)
  • Table 252. Europe Microarray, by Country USD Million (2019-2024)
  • Table 253. Europe Microarray, by Type USD Million (2019-2024)
  • Table 254. Europe Microarray, by Application USD Million (2019-2024)
  • Table 255. Europe Microarray, by End Use USD Million (2019-2024)
  • Table 256. Germany Microarray, by Type USD Million (2019-2024)
  • Table 257. Germany Microarray, by Application USD Million (2019-2024)
  • Table 258. Germany Microarray, by End Use USD Million (2019-2024)
  • Table 259. France Microarray, by Type USD Million (2019-2024)
  • Table 260. France Microarray, by Application USD Million (2019-2024)
  • Table 261. France Microarray, by End Use USD Million (2019-2024)
  • Table 262. Italy Microarray, by Type USD Million (2019-2024)
  • Table 263. Italy Microarray, by Application USD Million (2019-2024)
  • Table 264. Italy Microarray, by End Use USD Million (2019-2024)
  • Table 265. United Kingdom Microarray, by Type USD Million (2019-2024)
  • Table 266. United Kingdom Microarray, by Application USD Million (2019-2024)
  • Table 267. United Kingdom Microarray, by End Use USD Million (2019-2024)
  • Table 268. Netherlands Microarray, by Type USD Million (2019-2024)
  • Table 269. Netherlands Microarray, by Application USD Million (2019-2024)
  • Table 270. Netherlands Microarray, by End Use USD Million (2019-2024)
  • Table 271. Rest of Europe Microarray, by Type USD Million (2019-2024)
  • Table 272. Rest of Europe Microarray, by Application USD Million (2019-2024)
  • Table 273. Rest of Europe Microarray, by End Use USD Million (2019-2024)
  • Table 274. MEA Microarray, by Country USD Million (2019-2024)
  • Table 275. MEA Microarray, by Type USD Million (2019-2024)
  • Table 276. MEA Microarray, by Application USD Million (2019-2024)
  • Table 277. MEA Microarray, by End Use USD Million (2019-2024)
  • Table 278. Middle East Microarray, by Type USD Million (2019-2024)
  • Table 279. Middle East Microarray, by Application USD Million (2019-2024)
  • Table 280. Middle East Microarray, by End Use USD Million (2019-2024)
  • Table 281. Africa Microarray, by Type USD Million (2019-2024)
  • Table 282. Africa Microarray, by Application USD Million (2019-2024)
  • Table 283. Africa Microarray, by End Use USD Million (2019-2024)
  • Table 284. North America Microarray, by Country USD Million (2019-2024)
  • Table 285. North America Microarray, by Type USD Million (2019-2024)
  • Table 286. North America Microarray, by Application USD Million (2019-2024)
  • Table 287. North America Microarray, by End Use USD Million (2019-2024)
  • Table 288. United States Microarray, by Type USD Million (2019-2024)
  • Table 289. United States Microarray, by Application USD Million (2019-2024)
  • Table 290. United States Microarray, by End Use USD Million (2019-2024)
  • Table 291. Canada Microarray, by Type USD Million (2019-2024)
  • Table 292. Canada Microarray, by Application USD Million (2019-2024)
  • Table 293. Canada Microarray, by End Use USD Million (2019-2024)
  • Table 294. Mexico Microarray, by Type USD Million (2019-2024)
  • Table 295. Mexico Microarray, by Application USD Million (2019-2024)
  • Table 296. Mexico Microarray, by End Use USD Million (2019-2024)
  • Table 297. Microarray Sales: by Type(Y)
  • Table 298. Microarray Sales DNA Microarray , by Region Y (2019-2024)
  • Table 299. Microarray Sales Oligonucleotide Microarray , by Region Y (2019-2024)
  • Table 300. Microarray Sales Protein Microarray , by Region Y (2019-2024)
  • Table 301. Microarray Sales Tissue Microarray , by Region Y (2019-2024)
  • Table 302. Microarray Sales: by Application(Y)
  • Table 303. Microarray Sales Gene expression , by Region Y (2019-2024)
  • Table 304. Microarray Sales Disease diagnosis and development , by Region Y (2019-2024)
  • Table 305. Microarray Sales: by End Use(Y)
  • Table 306. Microarray Sales Life Science Research , by Region Y (2019-2024)
  • Table 307. Microarray Sales Medical , by Region Y (2019-2024)
  • Table 308. Microarray Sales Others , by Region Y (2019-2024)
  • Table 309. South America Microarray Sales, by Country Y (2019-2024)
  • Table 310. South America Microarray Sales, by Type Y (2019-2024)
  • Table 311. South America Microarray Sales, by Application Y (2019-2024)
  • Table 312. South America Microarray Sales, by End Use Y (2019-2024)
  • Table 313. Brazil Microarray Sales, by Type Y (2019-2024)
  • Table 314. Brazil Microarray Sales, by Application Y (2019-2024)
  • Table 315. Brazil Microarray Sales, by End Use Y (2019-2024)
  • Table 316. Argentina Microarray Sales, by Type Y (2019-2024)
  • Table 317. Argentina Microarray Sales, by Application Y (2019-2024)
  • Table 318. Argentina Microarray Sales, by End Use Y (2019-2024)
  • Table 319. Rest of South America Microarray Sales, by Type Y (2019-2024)
  • Table 320. Rest of South America Microarray Sales, by Application Y (2019-2024)
  • Table 321. Rest of South America Microarray Sales, by End Use Y (2019-2024)
  • Table 322. Asia Pacific Microarray Sales, by Country Y (2019-2024)
  • Table 323. Asia Pacific Microarray Sales, by Type Y (2019-2024)
  • Table 324. Asia Pacific Microarray Sales, by Application Y (2019-2024)
  • Table 325. Asia Pacific Microarray Sales, by End Use Y (2019-2024)
  • Table 326. China Microarray Sales, by Type Y (2019-2024)
  • Table 327. China Microarray Sales, by Application Y (2019-2024)
  • Table 328. China Microarray Sales, by End Use Y (2019-2024)
  • Table 329. Japan Microarray Sales, by Type Y (2019-2024)
  • Table 330. Japan Microarray Sales, by Application Y (2019-2024)
  • Table 331. Japan Microarray Sales, by End Use Y (2019-2024)
  • Table 332. India Microarray Sales, by Type Y (2019-2024)
  • Table 333. India Microarray Sales, by Application Y (2019-2024)
  • Table 334. India Microarray Sales, by End Use Y (2019-2024)
  • Table 335. South Korea Microarray Sales, by Type Y (2019-2024)
  • Table 336. South Korea Microarray Sales, by Application Y (2019-2024)
  • Table 337. South Korea Microarray Sales, by End Use Y (2019-2024)
  • Table 338. Taiwan Microarray Sales, by Type Y (2019-2024)
  • Table 339. Taiwan Microarray Sales, by Application Y (2019-2024)
  • Table 340. Taiwan Microarray Sales, by End Use Y (2019-2024)
  • Table 341. Australia Microarray Sales, by Type Y (2019-2024)
  • Table 342. Australia Microarray Sales, by Application Y (2019-2024)
  • Table 343. Australia Microarray Sales, by End Use Y (2019-2024)
  • Table 344. Rest of Asia-Pacific Microarray Sales, by Type Y (2019-2024)
  • Table 345. Rest of Asia-Pacific Microarray Sales, by Application Y (2019-2024)
  • Table 346. Rest of Asia-Pacific Microarray Sales, by End Use Y (2019-2024)
  • Table 347. Europe Microarray Sales, by Country Y (2019-2024)
  • Table 348. Europe Microarray Sales, by Type Y (2019-2024)
  • Table 349. Europe Microarray Sales, by Application Y (2019-2024)
  • Table 350. Europe Microarray Sales, by End Use Y (2019-2024)
  • Table 351. Germany Microarray Sales, by Type Y (2019-2024)
  • Table 352. Germany Microarray Sales, by Application Y (2019-2024)
  • Table 353. Germany Microarray Sales, by End Use Y (2019-2024)
  • Table 354. France Microarray Sales, by Type Y (2019-2024)
  • Table 355. France Microarray Sales, by Application Y (2019-2024)
  • Table 356. France Microarray Sales, by End Use Y (2019-2024)
  • Table 357. Italy Microarray Sales, by Type Y (2019-2024)
  • Table 358. Italy Microarray Sales, by Application Y (2019-2024)
  • Table 359. Italy Microarray Sales, by End Use Y (2019-2024)
  • Table 360. United Kingdom Microarray Sales, by Type Y (2019-2024)
  • Table 361. United Kingdom Microarray Sales, by Application Y (2019-2024)
  • Table 362. United Kingdom Microarray Sales, by End Use Y (2019-2024)
  • Table 363. Netherlands Microarray Sales, by Type Y (2019-2024)
  • Table 364. Netherlands Microarray Sales, by Application Y (2019-2024)
  • Table 365. Netherlands Microarray Sales, by End Use Y (2019-2024)
  • Table 366. Rest of Europe Microarray Sales, by Type Y (2019-2024)
  • Table 367. Rest of Europe Microarray Sales, by Application Y (2019-2024)
  • Table 368. Rest of Europe Microarray Sales, by End Use Y (2019-2024)
  • Table 369. MEA Microarray Sales, by Country Y (2019-2024)
  • Table 370. MEA Microarray Sales, by Type Y (2019-2024)
  • Table 371. MEA Microarray Sales, by Application Y (2019-2024)
  • Table 372. MEA Microarray Sales, by End Use Y (2019-2024)
  • Table 373. Middle East Microarray Sales, by Type Y (2019-2024)
  • Table 374. Middle East Microarray Sales, by Application Y (2019-2024)
  • Table 375. Middle East Microarray Sales, by End Use Y (2019-2024)
  • Table 376. Africa Microarray Sales, by Type Y (2019-2024)
  • Table 377. Africa Microarray Sales, by Application Y (2019-2024)
  • Table 378. Africa Microarray Sales, by End Use Y (2019-2024)
  • Table 379. North America Microarray Sales, by Country Y (2019-2024)
  • Table 380. North America Microarray Sales, by Type Y (2019-2024)
  • Table 381. North America Microarray Sales, by Application Y (2019-2024)
  • Table 382. North America Microarray Sales, by End Use Y (2019-2024)
  • Table 383. United States Microarray Sales, by Type Y (2019-2024)
  • Table 384. United States Microarray Sales, by Application Y (2019-2024)
  • Table 385. United States Microarray Sales, by End Use Y (2019-2024)
  • Table 386. Canada Microarray Sales, by Type Y (2019-2024)
  • Table 387. Canada Microarray Sales, by Application Y (2019-2024)
  • Table 388. Canada Microarray Sales, by End Use Y (2019-2024)
  • Table 389. Mexico Microarray Sales, by Type Y (2019-2024)
  • Table 390. Mexico Microarray Sales, by Application Y (2019-2024)
  • Table 391. Mexico Microarray Sales, by End Use Y (2019-2024)
  • Table 392. Microarray: by Type(USD/Units)
  • Table 393. Research Programs/Design for This Report
  • Table 394. Key Data Information from Secondary Sources
  • Table 395. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Microarray: by Type USD Million (2013-2018)
  • Figure 5. Global Microarray: by Application USD Million (2013-2018)
  • Figure 6. Global Microarray: by End Use USD Million (2013-2018)
  • Figure 7. South America Microarray Share (%), by Country
  • Figure 8. Asia Pacific Microarray Share (%), by Country
  • Figure 9. Europe Microarray Share (%), by Country
  • Figure 10. MEA Microarray Share (%), by Country
  • Figure 11. North America Microarray Share (%), by Country
  • Figure 12. Global Microarray: by Type Y (2013-2018)
  • Figure 13. Global Microarray: by Application Y (2013-2018)
  • Figure 14. Global Microarray: by End Use Y (2013-2018)
  • Figure 15. South America Microarray Share (%), by Country
  • Figure 16. Asia Pacific Microarray Share (%), by Country
  • Figure 17. Europe Microarray Share (%), by Country
  • Figure 18. MEA Microarray Share (%), by Country
  • Figure 19. North America Microarray Share (%), by Country
  • Figure 20. Global Microarray: by Type USD/Units (2013-2018)
  • Figure 21. Global Microarray share by Players 2018 (%)
  • Figure 22. Global Microarray share by Players (Top 3) 2018(%)
  • Figure 23. Global Microarray share by Players (Top 5) 2018(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Thermo Fischer Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 26. Thermo Fischer Scientific (United States) Revenue: by Geography 2018
  • Figure 27. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 28. Agilent Technologies (United States) Revenue: by Geography 2018
  • Figure 29. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 30. Merck (United States) Revenue: by Geography 2018
  • Figure 31. Illumina Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Illumina Inc. (United States) Revenue: by Geography 2018
  • Figure 33. Phalanx Biotech (Taiwan) Revenue, Net Income and Gross profit
  • Figure 34. Phalanx Biotech (Taiwan) Revenue: by Geography 2018
  • Figure 35. Biometrix Technology (Korea) Revenue, Net Income and Gross profit
  • Figure 36. Biometrix Technology (Korea) Revenue: by Geography 2018
  • Figure 37. Perkin Elmer (United States) Revenue, Net Income and Gross profit
  • Figure 38. Perkin Elmer (United States) Revenue: by Geography 2018
  • Figure 39. Applied Microarrays (United States) Revenue, Net Income and Gross profit
  • Figure 40. Applied Microarrays (United States) Revenue: by Geography 2018
  • Figure 41. Array It Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 42. Array It Corporation (United States) Revenue: by Geography 2018
  • Figure 43. TAKARA BIO INC. (Japan) Revenue, Net Income and Gross profit
  • Figure 44. TAKARA BIO INC. (Japan) Revenue: by Geography 2018
  • Figure 45. Global Microarray: by Type USD Million (2019-2024)
  • Figure 46. Global Microarray: by Application USD Million (2019-2024)
  • Figure 47. Global Microarray: by End Use USD Million (2019-2024)
  • Figure 48. South America Microarray Share (%), by Country
  • Figure 49. Asia Pacific Microarray Share (%), by Country
  • Figure 50. Europe Microarray Share (%), by Country
  • Figure 51. MEA Microarray Share (%), by Country
  • Figure 52. North America Microarray Share (%), by Country
  • Figure 53. Global Microarray: by Type Y (2019-2024)
  • Figure 54. Global Microarray: by Application Y (2019-2024)
  • Figure 55. Global Microarray: by End Use Y (2019-2024)
  • Figure 56. South America Microarray Share (%), by Country
  • Figure 57. Asia Pacific Microarray Share (%), by Country
  • Figure 58. Europe Microarray Share (%), by Country
  • Figure 59. MEA Microarray Share (%), by Country
  • Figure 60. North America Microarray Share (%), by Country
  • Figure 61. Global Microarray: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Thermo Fischer Scientific (United States)
  • Agilent Technologies (United States)
  • Merck (United States)
  • Illumina Inc. (United States)
  • Phalanx Biotech (Taiwan)
  • Biometrix Technology (Korea)
  • Perkin Elmer (United States)
  • Applied Microarrays (United States)
  • Array It Corporation (United States)
  • TAKARA BIO INC. (Japan)
Additional players considered in the study are as follows:
BioGenex (United States) , LC Sciences (United States) , US Biomax (United States) , AXO Science (France) , Qiagen (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation